A high-throughput screening assay for eukaryotic elongation factor 2 kinase inhibitors

Eukaryotic elongation factor 2 kinase (eEF2K) inhibitors may aid in the development of new therapeutic agents to combat cancer. Purified human eEF2K was obtained from an Escherichia coli expression system and a luminescence-based high-throughput screening (HTS) assay was developed using MH-1 peptide...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Ting, Liu, Rui, Proud, Christopher G., Wang, Ming-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071636/
https://www.ncbi.nlm.nih.gov/pubmed/27818922
http://dx.doi.org/10.1016/j.apsb.2016.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071636/
https://www.ncbi.nlm.nih.gov/pubmed/27818922
http://dx.doi.org/10.1016/j.apsb.2016.04.002

Ejemplares similares